Sanjiv.Parant.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE860D01013
NSEID:
BSEID: 531569

INR

235.95

7 (3.06%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.69 k

{
  "main_header": {
    "sid": 328426,
    "name": "Sanjiv.Parant.",
    "stock_name": "Sanjiv.Parant.",
    "full_name": "Sanjivani Paranteral Ltd",
    "name_url": "stocks-analysis/sanjivparant",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "235.95",
    "chg": 7,
    "chgp": "3.06%",
    "dir": 1,
    "prev_price": "228.95",
    "mcapval": "280.35 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531569,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE860D01013",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:12 AM",
    "bse_nse_vol": "1.69 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanjivani Paranteral Faces Short-Term Challenges Amid Long-Term Growth Success",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-reports-61-68-annual-growth-despite-recent-stock-decline-1682384",
        "imagepath": "",
        "date": "2025-04-02 18:00:17",
        "description": "Sanjivani Paranteral Ltd, a microcap player in the Pharmaceuticals & Drugs industry, has experienced notable fluctuations in its stock performance today. The company, with a market capitalization of Rs 303.00 crore, currently holds a price-to-earnings (P/E) ratio of 40.77, which is above the industry average of 34.70.\n\nOver the past year, Sanjivani Paranteral has shown a remarkable performance increase of 61.68%, significantly outpacing the Sensex, which rose by only 3.67%. However, recent trends indicate a decline, with the stock down 1.60% today, mirroring a broader market trend where the Sensex gained 0.78%. \n\nIn the short term, the stock has faced challenges, with a 1-week performance decline of 1.60% and a more substantial drop of 9.24% over the past month. Year-to-date, the stock has decreased by 35.60%, contrasting with the Sensex's modest decline of 1.95%. \n\nDespite these recent setbacks, Sanjivani ..."
      },
      {
        "title": "Sanjivani Paranteral Ltd Sees Strong Buying Amid Market Challenges and Price Movements",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-gains-67-71-yearly-despite-recent-decline-stock-hits-intraday-low-of-rs-230-35-1657720",
        "imagepath": "",
        "date": "2025-04-01 10:15:31",
        "description": "Sanjivani Paranteral Ltd, a microcap player in the Pharmaceuticals & Drugs sector, is currently witnessing strong buying activity despite a challenging market backdrop. Today, the stock has shown a slight decline of 0.49%, outperforming the Sensex, which is down by 0.70%. Over the past week, however, Sanjivani has faced a more significant drop of 5.04%, contrasting with the Sensex's modest gain of 0.20%.\n\nIn terms of longer-term performance, Sanjivani Paranteral has experienced a notable increase of 67.71% over the past year, significantly outpacing the Sensex's 4.63% rise. However, year-to-date, the stock is down 34.12%, while the Sensex has only declined by 1.38%. Over three and five years, Sanjivani has shown remarkable growth of 285.67% and 2792.53%, respectively, compared to the Sensex's 33.80% and 158.46%.\n\nToday's trading opened with a gap down of 4.8%, reaching an intraday low of Rs 230.35, reflecti..."
      },
      {
        "title": "Sanjivani Paranteral Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-faces-significant-selling-pressure-with-35-86-year-to-date-loss-and-3-12-decline-today-1647388",
        "imagepath": "",
        "date": "2025-03-28 15:35:07",
        "description": "Sanjivani Paranteral Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 3.12% in today's trading session, compared to a modest drop of 0.25% in the Sensex. Over the past week, Sanjivani Paranteral has lost 7.55%, while the Sensex has gained 0.66%. \n\nIn the month, the stock has decreased by 9.61%, contrasting sharply with the Sensex's increase of 5.76%. The three-month performance reveals a substantial decline of 33.31% for Sanjivani Paranteral, while the Sensex has only dipped by 1.63%. Year-to-date, the stock is down 35.86%, significantly underperforming the Sensex, which has seen a slight decline of 0.93%. \n\nToday's trading saw the stock open with a gain of 3.99%, reaching an intraday high of Rs 263, but it quickly fell to a low of Rs 238.6, marking a decline of 5.65%. The stock ..."
      },
      {
        "title": "Sanjivani Paranteral Ltd Experiences Notable Gains Amid Increased Buying Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-surges-3-20-today-marking-4-31-gain-over-two-days-1405073",
        "imagepath": "",
        "date": "2025-03-17 10:40:06",
        "description": "Sanjivani Paranteral Ltd, a microcap player in the Pharmaceuticals & Drugs sector, is witnessing significant buying activity, with the stock gaining 3.20% today, outperforming the Sensex, which rose by only 0.30%. This marks the second consecutive day of gains for Sanjivani Paranteral, accumulating a total return of 4.31% over this period. \n\nThe stock reached an intraday high of Rs 266, reflecting a 2.62% increase during the trading session. Over the past week, Sanjivani Paranteral has shown a modest gain of 0.49%, contrasting with the Sensex's slight decline of 0.09%. However, its performance over the longer term reveals a mixed picture, with a notable 98.81% increase over the past year, significantly outpacing the Sensex's 1.94% rise.\n\nDespite recent volatility, including a 20.39% decline over the past three months, the stock's performance remains strong on a yearly basis. Factors contributing to the curr..."
      },
      {
        "title": "Sanjivani Paranteral Shows Stability Amidst Mixed Market Signals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-stock-downgraded-to-sell-amid-flat-financial-performance-2-1178213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/SanjivaniParant_mojoScore_563358.png",
        "date": "2025-03-03 18:01:13",
        "description": "Sanjivani Paranteral, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation, reflecting stable financial performance for Q3 FY24-25. The company reported a 21.3% profit increase and a 44.02% return over the past year, although its stock valuation appears high compared to peers."
      },
      {
        "title": "Sanjivani Paranteral Faces Intense Selling Pressure Amid Consecutive Losses and Declining Stock Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-faces-heavy-selling-pressure-with-5-decline-amid-ongoing-losses-1173192",
        "imagepath": "",
        "date": "2025-03-03 10:23:27",
        "description": "Sanjivani Paranteral Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past three days, resulting in a total decline of 12.68%. Today, the stock fell by 5.00%, underperforming the Sensex, which decreased by only 0.47%. \n\nIn the past week, Sanjivani Paranteral has seen a decline of 9.90%, compared to the Sensex's 2.15% drop. Over the last month, the stock has plummeted by 23.82%, while the Sensex has lost 5.61%. Year-to-date, Sanjivani Paranteral is down 32.59%, significantly underperforming the Sensex's 6.76% decline.\n\nThe stock's performance metrics indicate it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. The intraday trading saw a high of Rs 280.95 and a low of Rs 262. Potential contributing factors to the selling pressure may include broad..."
      },
      {
        "title": "Sanjivani Paranteral Ltd Achieves Five Consecutive Days of Gains Amid Strong Buying Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-surges-4-99-marks-fifth-consecutive-day-of-gains-with-17-12-weekly-rise-1114625",
        "imagepath": "",
        "date": "2025-02-25 15:21:37",
        "description": "Sanjivani Paranteral Ltd is witnessing significant buying activity, with the stock gaining 4.99% today, outperforming the Sensex, which rose only 0.14%. Over the past week, Sanjivani has shown impressive performance, with a 17.12% increase, while the Sensex declined by 1.85%. This marks five consecutive days of gains for the microcap pharmaceutical company, reflecting a strong upward trend.\n\nThe stock opened with a gap up of 4.27% and reached an intraday high of Rs 300.05. Despite a challenging month where it fell by 14.15%, Sanjivani's year-to-date performance shows a decline of 21.45%, compared to the Sensex's 4.58% drop. However, the company has demonstrated remarkable long-term growth, with a staggering 442.10% increase over three years and an impressive 3348.85% rise over five years.\n\nFactors contributing to the current buying pressure may include recent developments within the company or sector-specif..."
      },
      {
        "title": "Sanjivani Paranteral Shows Strong Technical Trends Amid Market Dynamics Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranterals-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-price-increase-1111499",
        "imagepath": "",
        "date": "2025-02-25 10:28:35",
        "description": "Sanjivani Paranteral, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 296.00, showing a notable increase from the previous close of 285.80. Over the past year, Sanjivani has demonstrated impressive resilience, with a return of 68.42%, significantly outperforming the Sensex, which recorded a return of just 2.09% during the same period.\n\nIn terms of technical indicators, the stock's moving averages on a daily basis suggest a positive trend, while the MACD and Bollinger Bands present a mixed picture across weekly and monthly assessments. The KST and Dow Theory indicators indicate a more cautious stance in the short term. \n\nSanjivani's performance over various time frames highlights its strong recovery, particularly over the last three and five years, where it achieved returns of 434..."
      },
      {
        "title": "Sanjivani Paranteral Shows Stability Amid Promising Long-Term Growth Prospects",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-receives-hold-upgrade-amid-flat-financial-performance-1107343",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/SanjivaniParant_mojoScore_509573.png",
        "date": "2025-02-24 18:10:57",
        "description": "Sanjivani Paranteral, a microcap in the Pharmaceuticals & Drugs sector, recently experienced a score adjustment amid stable financial performance for Q3 FY24-25. The company shows a promising long-term growth trajectory, with a significant annual increase in operating profit and a strong return on equity, despite a high price-to-book ratio."
      }
    ],
    "total": 105,
    "sid": "328426",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/sanjivani-paranteral-328426"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2025",
      "details": "Compliance Certificate under Regulation 74(5) for the Quarter ended 31st March 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Closure of Trading Window for Quarter and Year Ended 31st March 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "15-Feb-2025",
      "details": "Earnings Call Transcript Conducted on 11th February 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sanjivani Paranteral Faces Short-Term Challenges Amid Long-Term Growth Success

2025-04-02 18:00:17

Sanjivani Paranteral Ltd, a microcap player in the Pharmaceuticals & Drugs industry, has experienced notable fluctuations in its stock performance today. The company, with a market capitalization of Rs 303.00 crore, currently holds a price-to-earnings (P/E) ratio of 40.77, which is above the industry average of 34.70. Over the past year, Sanjivani Paranteral has shown a remarkable performance increase of 61.68%, significantly outpacing the Sensex, which rose by only 3.67%. However, recent trends indicate a decline, with the stock down 1.60% today, mirroring a broader market trend where the Sensex gained 0.78%. In the short term, the stock has faced challenges, with a 1-week performance decline of 1.60% and a more substantial drop of 9.24% over the past month. Year-to-date, the stock has decreased by 35.60%, contrasting with the Sensex's modest decline of 1.95%. Despite these recent setbacks, Sanjivani ...

Sanjivani Paranteral Ltd Sees Strong Buying Amid Market Challenges and Price Movements

2025-04-01 10:15:31

Sanjivani Paranteral Ltd, a microcap player in the Pharmaceuticals & Drugs sector, is currently witnessing strong buying activity despite a challenging market backdrop. Today, the stock has shown a slight decline of 0.49%, outperforming the Sensex, which is down by 0.70%. Over the past week, however, Sanjivani has faced a more significant drop of 5.04%, contrasting with the Sensex's modest gain of 0.20%. In terms of longer-term performance, Sanjivani Paranteral has experienced a notable increase of 67.71% over the past year, significantly outpacing the Sensex's 4.63% rise. However, year-to-date, the stock is down 34.12%, while the Sensex has only declined by 1.38%. Over three and five years, Sanjivani has shown remarkable growth of 285.67% and 2792.53%, respectively, compared to the Sensex's 33.80% and 158.46%. Today's trading opened with a gap down of 4.8%, reaching an intraday low of Rs 230.35, reflecti...

Sanjivani Paranteral Faces Intense Selling Pressure Amid Significant Price Declines

2025-03-28 15:35:07

Sanjivani Paranteral Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 3.12% in today's trading session, compared to a modest drop of 0.25% in the Sensex. Over the past week, Sanjivani Paranteral has lost 7.55%, while the Sensex has gained 0.66%. In the month, the stock has decreased by 9.61%, contrasting sharply with the Sensex's increase of 5.76%. The three-month performance reveals a substantial decline of 33.31% for Sanjivani Paranteral, while the Sensex has only dipped by 1.63%. Year-to-date, the stock is down 35.86%, significantly underperforming the Sensex, which has seen a slight decline of 0.93%. Today's trading saw the stock open with a gain of 3.99%, reaching an intraday high of Rs 263, but it quickly fell to a low of Rs 238.6, marking a decline of 5.65%. The stock ...

Sanjivani Paranteral Ltd Experiences Notable Gains Amid Increased Buying Activity

2025-03-17 10:40:06

Sanjivani Paranteral Ltd, a microcap player in the Pharmaceuticals & Drugs sector, is witnessing significant buying activity, with the stock gaining 3.20% today, outperforming the Sensex, which rose by only 0.30%. This marks the second consecutive day of gains for Sanjivani Paranteral, accumulating a total return of 4.31% over this period. The stock reached an intraday high of Rs 266, reflecting a 2.62% increase during the trading session. Over the past week, Sanjivani Paranteral has shown a modest gain of 0.49%, contrasting with the Sensex's slight decline of 0.09%. However, its performance over the longer term reveals a mixed picture, with a notable 98.81% increase over the past year, significantly outpacing the Sensex's 1.94% rise. Despite recent volatility, including a 20.39% decline over the past three months, the stock's performance remains strong on a yearly basis. Factors contributing to the curr...

Sanjivani Paranteral Shows Stability Amidst Mixed Market Signals and Valuation Concerns

2025-03-03 18:01:13

Sanjivani Paranteral, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation, reflecting stable financial performance for Q3 FY24-25. The company reported a 21.3% profit increase and a 44.02% return over the past year, although its stock valuation appears high compared to peers.

Sanjivani Paranteral Faces Intense Selling Pressure Amid Consecutive Losses and Declining Stock Performance

2025-03-03 10:23:27

Sanjivani Paranteral Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past three days, resulting in a total decline of 12.68%. Today, the stock fell by 5.00%, underperforming the Sensex, which decreased by only 0.47%. In the past week, Sanjivani Paranteral has seen a decline of 9.90%, compared to the Sensex's 2.15% drop. Over the last month, the stock has plummeted by 23.82%, while the Sensex has lost 5.61%. Year-to-date, Sanjivani Paranteral is down 32.59%, significantly underperforming the Sensex's 6.76% decline. The stock's performance metrics indicate it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. The intraday trading saw a high of Rs 280.95 and a low of Rs 262. Potential contributing factors to the selling pressure may include broad...

Sanjivani Paranteral Ltd Achieves Five Consecutive Days of Gains Amid Strong Buying Activity

2025-02-25 15:21:37

Sanjivani Paranteral Ltd is witnessing significant buying activity, with the stock gaining 4.99% today, outperforming the Sensex, which rose only 0.14%. Over the past week, Sanjivani has shown impressive performance, with a 17.12% increase, while the Sensex declined by 1.85%. This marks five consecutive days of gains for the microcap pharmaceutical company, reflecting a strong upward trend. The stock opened with a gap up of 4.27% and reached an intraday high of Rs 300.05. Despite a challenging month where it fell by 14.15%, Sanjivani's year-to-date performance shows a decline of 21.45%, compared to the Sensex's 4.58% drop. However, the company has demonstrated remarkable long-term growth, with a staggering 442.10% increase over three years and an impressive 3348.85% rise over five years. Factors contributing to the current buying pressure may include recent developments within the company or sector-specif...

Sanjivani Paranteral Shows Strong Technical Trends Amid Market Dynamics Shift

2025-02-25 10:28:35

Sanjivani Paranteral, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 296.00, showing a notable increase from the previous close of 285.80. Over the past year, Sanjivani has demonstrated impressive resilience, with a return of 68.42%, significantly outperforming the Sensex, which recorded a return of just 2.09% during the same period. In terms of technical indicators, the stock's moving averages on a daily basis suggest a positive trend, while the MACD and Bollinger Bands present a mixed picture across weekly and monthly assessments. The KST and Dow Theory indicators indicate a more cautious stance in the short term. Sanjivani's performance over various time frames highlights its strong recovery, particularly over the last three and five years, where it achieved returns of 434...

Sanjivani Paranteral Shows Stability Amid Promising Long-Term Growth Prospects

2025-02-24 18:10:57

Sanjivani Paranteral, a microcap in the Pharmaceuticals & Drugs sector, recently experienced a score adjustment amid stable financial performance for Q3 FY24-25. The company shows a promising long-term growth trajectory, with a significant annual increase in operating profit and a strong return on equity, despite a high price-to-book ratio.